UCB (EBR:UCB) UCB Media Room: Disposals of own shares

Transparency directive : regulatory news

22/02/2021 20:02

26/02/2021 20:02
25/02/2021 07:02
23/02/2021 07:03
22/02/2021 20:02
05/02/2021 07:02
29/01/2021 20:02
22/01/2021 20:02
15/01/2021 07:02
13/01/2021 07:01
09/01/2021 20:01 ** Disposals of own shares ------------------------------------------------------------ Brussels (Belgium), 22 February 2021 =E2=80=93 20:00 (CET) =E2=80=93 regula= ted information In accordance with article 8:6 of the Royal Decree executing the Belgian Co= de of Companies and Associations, UCB SA/NV (=E2=80=9CUCB=E2=80=9D or the = =E2=80=9CCompany) (Euronext Brussels: UCB) announces that, following exerci= ses of stock options by members of its personnel, it has disposed of UCB sh= ares OTC in view of deliveries of these shares to the relevant members of t= he personnel, within the framework of the Long Term Incentive Program of th= e UCB Group, as follows: This press release is available on UCB SA/NV=E2=80=99s website via the foll= owing link ( . Investor Relations Antje Witte =C2=A0 =C2=A0 =C2=A0 =C2=A0 =C2=A0 Investor Relations, UCB T +32.2.559.94.14 Isabelle Ghellynck, =C2=A0Investor Relations, UCB T+32.2.559.9588, About UCB UCB, Brussels, Belgium ( is a global biopharmaceutical company = focused on the discovery and development of innovative medicines and soluti= ons to transform the lives of people living with severe diseases of the imm= une system or of the central nervous system. With 7 500 people in approxima= tely 40 countries, the company generated revenue of =E2=82=AC 4.9 billion i= n 2019. UCB is listed on Euronext Brussels (symbol: UCB). Follow us on Twit= ter: @UCB_news GenericFile 210222 - Vervreemding van eigen aandelen ( 5/3293563/ad918cd56937ef5b.pdf) GenericFile 210222 - Disposals of own shares ( 3/b9bf065151366412.pdf) GenericFile 210222 - Ali=C3=A9nation d actions propres ( 595/3293563/b7559873d0317c7e.pdf) Image Chart 1 Feb 22 2021 ( 01139_org.png)=0D =0D ______________________=0D If you would rather not receive future communications from UCB SA, please g= o to x6& UCB SA, All=C3=A9e de la Recherche, 60 ., Brussels, . B - 1070 Belgium=